SCHEMBL2155754

SCHEMBL2155754

COc1ccc(C(=O)O)c(CC2(Cc3cc(OC)ccc3C(=O)O)CSc3ccccc3C2=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.43
LMNA P02545 2/20 0.43
ACHE P22303 2/20 0.42
AKR1C3 P42330 2/20 0.39
AKR1C2 P52895 2/20 0.39
RAB9A P51151 3/20 0.37
FOLH1 Q04609 1/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
TP53 P04637 1/20 0.36
NOX1 Q9Y5S8 1/20 0.36
CYP1A2 P05177 1/20 0.36
PGR P06401 1/20 0.36
CYP3A4 P08684 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
AR P10275 1/20 0.36
CHRM1 P11229 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
TBXA2R P21731 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2155684 0.83 ACHE (0.40) MAPTLMNAACHEFOLH1
SCHEMBL2157029 0.82 HTR2A (0.45) MAPTLMNAAKR1C3AKR1C2RAB9A
SCHEMBL2155984 0.79 AKR1C3 (0.44) MAPTAKR1C3AKR1C2RAB9AFOLH1
SCHEMBL2156133 0.75 LMNA (0.47) MAPTLMNAACHEGAA
SCHEMBL2155863 0.73 LMNA (0.37) MAPTLMNAACHEFOLH1GAA
SCHEMBL2156603 0.70 CYP19A1 (0.43) MAPTLMNAAKR1C3AKR1C2RAB9A
SCHEMBL2155997 0.68 MAPT (0.44) MAPTLMNAACHERAB9APOLB
SCHEMBL687106 0.67 KDM4E (0.53) LMNAAKR1C3AKR1C2RAB9APOLB
SCHEMBL3098374 0.67 MTNR1A (0.58) LMNAAKR1C3AKR1C2RAB9ASMN1; SMN2
SCHEMBL8478030 0.66 SMN1; SMN2 (0.56) LMNAAKR1C3AKR1C2RAB9AFOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161352-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives and the Use Thereof for Medicament Production GRUENENTHAL GMBH (DE) 2008-07-03 US claimed
US-7973072-B2 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example GRUENENTHAL GMBH (DE) 2011-07-05 US disclosed
US-20080161352-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives and the Use Thereof for Medicament Production GRUENENTHAL GMBH (DE) 2008-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161352-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives and the Use Thereof for Medicament Production BCKDK, SYMPK, DHPS MAPT 3287/4885LMNA 3109/4885ACHE 3986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.